Thoracic Injuries: Clinical Trials

13 trials for Thoracic Injuries, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown, 3 completed, 3 withdrawn, 2 terminated. 13 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 113Unknown 5, Completed 3, Withdrawn 3, Terminated 2
Phase 24Unknown 2, Terminated 1, Withdrawn 1

Follow Thoracic Injuries: new trials by email Literature Review of Thoracic Injuries trials Research Report on Thoracic Injuries

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ultrasound Guided Emergency Physician Performed Erector Spinae Nerve Block for Rib Fracture Analgesia
ESP block with bupivacaine, Saline control/sham injection - Rib Fractures
Phase 1 / Phase 2WithdrawnYale University2025-05-012025-07-01
Stem Cell Treatment for Lung Injury Caused by Major Infectious Diseases
mesenchymal stem cells, saline - Lung Injury
Phase 1 / Phase 2UnknownCell Energy Life Sciences Group Co. LTD802023-05-102024-05-16
Inhibition of Plasma Kallikrein as a New Therapy for Lung Injury
Lanadelumab, Saline control - Lung Injury
Phase 1UnknownSt Vincent's Institute of Medical Research482021-08-092024-04-17
Effect of Human Umbilical Cord-derived Mesenchymal Stem Cells on Non-cardiac Surgery-induced Lung Injury
human umbilical cord-derived mesenchymal stem cells, saline - Ischemic Heart Disease, Lung Injury
Phase 1UnknownShanghai East Hospital162021-08-012023-12-19
RAPA-501-Allo Therapy of COVID-19-ARDS
RAPA-501-Allo off-the-shelf Therapy of COVID-19, Placebo - Severe COVID-19 Disease
Phase 1 / Phase 2TerminatedRapa Therapeutics LLC12020-12-302021-11-11
CLBS119 for Repair of COVID-19 Induced Pulmonary Damage
CLBS119 - Covid-19
Phase 1WithdrawnLisata Therapeutics, Inc.2020-10-052024-10-09
The Erector Spinae Plane Block and Its Effect on Respiratory Status and Pain Management in Rib Fracture Patients
Ropivacaine, Normal Saline Flush, 0.9% Injectable Solution - Rib Fractures
Phase 1TerminatedVirginia Commonwealth University42019-05-242020-08-07
Lung and Diaphragm-Protective Ventilation by Means of Assessing Respiratory Work
Lung- and Diaphragm-Protective Ventilation - Diaphragm Injury, Lung Injury
Phase 1CompletedUniversity Health Network, Toronto232019-02-012024-12-10
Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Paraquat Poisoning Induced Lung Injury
UCMSC group, Control group(Normal saline) - Paraquat Poisoning, Lung Injury
Phase 1 / Phase 2UnknownAffiliated Hospital to Academy of Military Medical Sciences402015-05-012015-05-15
Infant Pulmonary Mechanics: High Flow Nasal Cannula Versus Nasal CPAP
Heated Humidified High Flow Nasal Cannula, Nasal Continuous Positive Airway Pressure - Respiratory Distress, Lung Injury
Phase 1WithdrawnChildren's Hospital of Philadelphia2014-03-012015-09-15
A Study to Investigate the Safety Tolerability Pharmacokinetics, and Pharmacodynamics of Inhaled and Intravenous GSK2862277 in Healthy Volunteers
Single IV dose of GSK2862277, Matching placebo single dose IV infusion, Single IH dose of GSK2862277 - Respiratory Disorders
Phase 1CompletedGlaxoSmithKline542013-02-222017-05-15
Safety Study of Nebulized Sodium Nitroprusside in Adult Acute Lung Injury
Sodium Nitroprusside - Acute Lung Injury, Acute Respiratory Distress Syndrome
Phase 1UnknownMount Sinai Hospital, Canada302012-05-012012-06-14
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Inhaled GSK1995057
GSK1995057, bronchoalveolar lavage, LPS - Respiratory Disorders
Phase 1CompletedGlaxoSmithKline532012-03-282019-06-27

Narrower conditions

Lung Injury (11)  ·  Respiratory Distress Syndrome (3)  ·  Respiratory Insufficiency (3)  ·  Acute Lung Injury (2)  ·  COVID-19 (2)  ·  Coronavirus Infections (2)  ·  Lung Diseases (2)  ·  Pneumonia (2)  ·  Respiration Disorders (2)  ·  Rib Fractures (2)  ·  Cytokine Release Syndrome (1)  ·  Dyspnea (1)  ·  Hypoxia (1)  ·  Infections (1)  ·  Myocardial Ischemia (1)

Broader conditions

Wounds and Injuries (13)  ·  Respiratory Tract Diseases (10)  ·  Lung Diseases (9)  ·  Respiration Disorders (5)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Coronaviridae Infections (2)  ·  Fractures, Bone (2)  ·  Infections (2)  ·  Nidovirales Infections (2)  ·  Pneumonia, Viral (2)  ·  RNA Virus Infections (2)  ·  Respiratory Tract Infections (2)  ·  Signs and Symptoms (2)  ·  Signs and Symptoms, Respiratory (2)

Interventions

Sodium Chloride (3)  ·  Anesthetics, Local (1)  ·  Bronchoalveolar Lavage (1)  ·  Bupivacaine (1)  ·  Continuous Positive Airway Pressure (1)  ·  GSK1995057 (1)  ·  Infusions, Intravenous (1)  ·  Nitroprusside (1)  ·  Ropivacaine (1)  ·  lanadelumab (1)

Sponsors

GlaxoSmithKline (2)  ·  Affiliated Hospital to Academy of Military Medical Sciences (1)  ·  Cell Energy Life Sciences Group Co. LTD (1)  ·  Children's Hospital of Philadelphia (1)  ·  Lisata Therapeutics, Inc. (1)  ·  Mount Sinai Hospital, Canada (1)  ·  Rapa Therapeutics LLC (1)  ·  Shanghai East Hospital (1)  ·  St Vincent's Institute of Medical Research (1)  ·  University Health Network, Toronto (1)  ·  Virginia Commonwealth University (1)  ·  Yale University (1)

Countries

United States (4)  ·  China (3)  ·  Canada (2)  ·  United Kingdom (2)  ·  Australia (1)

Top investigators

Bing Liu, M.D. (1)  ·  Bryant Tran, MD (1)  ·  Chunyan Wang, M.D. (1)  ·  Cristiana Baloescu, MD (1)  ·  Daniel Fowler, M.D. (1)  ·  Douglas W Losordo, MD (1)  ·  Ewan Goligher, MD, PhD (1)  ·  Haochun Wang, M.D. (1)  ·  Sangeeta Mehta, MD FRCPC (1)  ·  Soraya Abbasi, MD (1)  ·  Terence Ip, MD (1)  ·  Xiangrui Wang (1)  ·  Xiaobo Peng, M.D. (1)

Results publications

PMID 26178412, PMID 29382797, PMID 36038890